95 related articles for article (PubMed ID: 8740582)
21. Concentration of the cross-linked carboxyterminal telopeptide of type I collagen in serum of young growing rats fed a low calcium and vitamin D-deficient diet.
Bielaczyc AR; Gołebiewska M; Citko A; Rogowski F
Eur J Clin Chem Clin Biochem; 1997 Dec; 35(12):915-8. PubMed ID: 9476619
[TBL] [Abstract][Full Text] [Related]
22. [Procollagen III and laminin in chronic viral hepatopathies].
Montalto G; Soresi M; Aragona F; Tripi S; Carroccio A; Anastasi G; Magliarisi C; Barresi E; Notarbartolo A
Presse Med; 1996 Jan; 25(2):59-62. PubMed ID: 8745719
[TBL] [Abstract][Full Text] [Related]
23. Intra-individual variation in serum type I procollagen carboxy-terminal propeptide and type I collagen carboxy-terminal cross-linked telopeptide concentrations.
Stevenson HP; Leslie H; Sheridan B
Ann Clin Biochem; 1997 May; 34 ( Pt 3)():317-8. PubMed ID: 9158832
[No Abstract] [Full Text] [Related]
24. Serum markers of type I collagen synthesis and degradation in amyotrophic lateral sclerosis.
Ono S; Imai T; Shimizu N; Nakayama M; Yamano T; Tsumura M
Eur Neurol; 2000; 44(1):49-56. PubMed ID: 10894996
[TBL] [Abstract][Full Text] [Related]
25. [Serum type IV collagen and laminin in patients with chronic hepatitis and its clinical significance].
Xie J; OuYang K; Su T
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):93-6. PubMed ID: 10681810
[TBL] [Abstract][Full Text] [Related]
26. [Correlation of serum markers with fibrosis staging in chronic viral hepatitis].
Wang T; Wang B; Liu X
Zhonghua Bing Li Xue Za Zhi; 1998 Jun; 27(3):185-90. PubMed ID: 11244978
[TBL] [Abstract][Full Text] [Related]
27. Serum concentration of pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with metastatic breast cancer.
Maemura M; Iino Y; Yokoe T; Takei H; Horiguchi J; Koibuchi Y; Ikeda F; Ohwada S; Takeyoshi I; Morishita Y
Oncol Rep; 2000; 7(6):1333-8. PubMed ID: 11032939
[TBL] [Abstract][Full Text] [Related]
28. Dupuytren's disease in type I diabetic subjects: investigation of biochemical markers of type III and I collagen.
Arkkila PE; Koskinen PJ; Kantola IM; Rönnemaa T; Seppänen E; Viikari JS
Clin Exp Rheumatol; 2000; 18(2):215-9. PubMed ID: 10812494
[TBL] [Abstract][Full Text] [Related]
29. Elevation of serum cystatin C concentrations in patients with chronic liver disease.
Takeuchi M; Fukuda Y; Nakano I; Katano Y; Hayakawa T
Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):951-5. PubMed ID: 11507361
[TBL] [Abstract][Full Text] [Related]
30. Circulating telopeptide type I is a peripheral marker of thyroid hormone action in hyperthyroidism and during levothyroxine suppressive therapy.
Loviselli A; Mastinu R; Rizzolo E; Massa GM; Velluzzi F; Sammartano L; Mela Q; Mariotti S
Thyroid; 1997 Aug; 7(4):561-6. PubMed ID: 9292943
[TBL] [Abstract][Full Text] [Related]
31. Type I and III collagen metabolites as predictors of clinical outcome in epithelial ovarian cancer.
Santala M; Simojoki M; Risteli J; Risteli L; Kauppila A
Clin Cancer Res; 1999 Dec; 5(12):4091-6. PubMed ID: 10632345
[TBL] [Abstract][Full Text] [Related]
32. Elevated levels of serum type I collagen C-telopeptide in patients with rapidly destructive osteoarthritis of the hip.
Berger CE; Kröner A; Stiegler H; Leitha T; Engel A
Int Orthop; 2005 Feb; 29(1):1-5. PubMed ID: 15625614
[TBL] [Abstract][Full Text] [Related]
33. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
[TBL] [Abstract][Full Text] [Related]
34. The significance of carboxy-terminal telopeptide of type I collagen (ICTP) and osteocalcin (OC) in assessment of bone disease in patients with multiple myeloma.
Kuliszkiewicz-Janus M; Małecki R; Zółtaszek A; Zastawny M
Leuk Lymphoma; 2005 Dec; 46(12):1749-53. PubMed ID: 16263577
[TBL] [Abstract][Full Text] [Related]
35. Detection of MAGE-4 protein in the sera of patients with hepatitis-C virus-associated hepatocellular carcinoma and liver cirrhosis.
Tsuzurahara S; Sata M; Iwamoto O; Shichijo S; Kojiro M; Tanikawa K; Itoh K
Jpn J Cancer Res; 1997 Sep; 88(9):915-8. PubMed ID: 9369941
[TBL] [Abstract][Full Text] [Related]
36. Serum cross-linked N-terminal telopeptide of type I collagen for evaluation of renal osteodystrophy in hemodialysis patients.
Nakashima A; Yorioka N; Mizutani T; Yamagata Z; Ueno T; Takasugi N
Nephron Clin Pract; 2005; 99(3):c78-85. PubMed ID: 15665550
[TBL] [Abstract][Full Text] [Related]
37. Assay for cross-linked carboxyterminal telopeptide of type I collagen (ICTP) unlike CrossLaps assay reflects increased pathological degradation of type I collagen in rheumatoid arthritis.
Sassi ML; Aman S; Hakala M; Luukkainen R; Risteli J
Clin Chem Lab Med; 2003 Aug; 41(8):1038-44. PubMed ID: 12964811
[TBL] [Abstract][Full Text] [Related]
38. Serum hyaluronan as a marker of liver fibrosis in hemophiliacs with hepatitis C virus-associated chronic liver disease.
Yamada M; Fukuda Y; Nakano I; Katano Y; Takamatsu J; Hayakawa T
Acta Haematol; 1998; 99(4):212-6. PubMed ID: 9644299
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
[TBL] [Abstract][Full Text] [Related]
40. [Serum levels of the carboxyterminal telopeptide of type I collagen in patients with thyroid disorders].
Conti A; Monzani M; Persani L; Sartorio A
Minerva Endocrinol; 1994 Sep; 19(3):127-31. PubMed ID: 7799894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
